Drug Price Debate Might Not Hinder Biotech ETFs
September 16, 2021 at 09:57 AM EDT
The issue of pharmaceuticals pricing reform — a long-time favorite discussion on Capitol Hill — is gaining momentum, and some healthcare assets are bearing that burden.